BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23817611)

  • 1. Severity of allergic airway disease due to house dust mite allergen is not increased after clinical recovery of lung infection with Chlamydia pneumoniae in mice.
    Dutow P; Lingner S; Laudeley R; Glage S; Hoymann HG; Dittrich AM; Fehlhaber B; Müller M; Braun A; Klos A
    Infect Immun; 2013 Sep; 81(9):3366-74. PubMed ID: 23817611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
    Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
    Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model.
    Verheijden KA; Willemsen LE; Braber S; Leusink-Muis T; Delsing DJ; Garssen J; Kraneveld AD; Folkerts G
    Respir Res; 2015 Feb; 16(1):17. PubMed ID: 25849971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung-homing of endothelial progenitor cells and airway vascularization is only partially dependant on eosinophils in a house dust mite-exposed mouse model of allergic asthma.
    Sivapalan N; Wattie J; Inman MD; Sehmi R
    PLoS One; 2014; 9(10):e109991. PubMed ID: 25279605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of peripheral airway function following chronic allergen challenge in a sheep model of asthma.
    Van der Velden J; Barker D; Barcham G; Koumoundouros E; Snibson K
    PLoS One; 2011; 6(12):e28740. PubMed ID: 22174883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent pulmonary reactivity to house dust mite allergen: a model of adult-onset asthma?
    Mack S; Shin J; Ahn Y; Castaneda AR; Peake J; Fulgar C; Zhang J; Cho YH; Pinkerton KE
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L757-L763. PubMed ID: 30840481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness.
    Tournoy KG; Kips JC; Schou C; Pauwels RA
    Clin Exp Allergy; 2000 Jan; 30(1):79-85. PubMed ID: 10606934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent dual allergen exposure and its effects on airway hyperresponsiveness, inflammation and remodeling in mice.
    DiGiovanni FA; Ellis R; Wattie J; Hirota JA; Southam DS; Inman MD
    Dis Model Mech; 2009; 2(5-6):275-82. PubMed ID: 19380307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of allergic airway disease using house dust mite allergen.
    Allen IC
    Methods Mol Biol; 2013; 1032():159-72. PubMed ID: 23943452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoke differentially affects eosinophilia and remodeling in a model of house dust mite asthma.
    Botelho FM; Llop-Guevara A; Trimble NJ; Nikota JK; Bauer CM; Lambert KN; Kianpour S; Jordana M; Stämpfli MR
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):753-60. PubMed ID: 21317378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchom assuages airway hyperresponsiveness in house dust mite-induced mouse model of allergic asthma and moderates goblet cell metaplasia, sub-epithelial fibrosis along with changes in Th2 cytokines and chemokines.
    Balkrishna A; Sinha S; Karumuri S; Maity M; Dev R; Varshney A
    Front Immunol; 2024; 15():1384697. PubMed ID: 38807596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. House dust mite-induced asthma causes oxidative damage and DNA double-strand breaks in the lungs.
    Chan TK; Loh XY; Peh HY; Tan WNF; Tan WSD; Li N; Tay IJJ; Wong WSF; Engelward BP
    J Allergy Clin Immunol; 2016 Jul; 138(1):84-96.e1. PubMed ID: 27157131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice.
    Saglani S; Mathie SA; Gregory LG; Bell MJ; Bush A; Lloyd CM
    Am J Respir Cell Mol Biol; 2009 Sep; 41(3):281-9. PubMed ID: 19151316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma.
    Lei Y; Boinapally V; Zoltowska A; Adner M; Hellman L; Nilsson G
    PLoS One; 2015; 10(7):e0133774. PubMed ID: 26214807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Exposure to House Dust Mite Leads to the Suppression of Allergic Airway Disease Despite Persistent Lung Inflammation.
    Bracken SJ; Adami AJ; Szczepanek SM; Ehsan M; Natarajan P; Guernsey LA; Shahriari N; Rafti E; Matson AP; Schramm CM; Thrall RS
    Int Arch Allergy Immunol; 2015; 166(4):243-58. PubMed ID: 25924733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of eosinophilic inflammation is independent of B-T cell interaction in a chronic house dust mite-driven asthma model.
    Vroman H; Bergen IM; Li BW; van Hulst JA; Lukkes M; van Uden D; Hendriks RW; Kool M
    Clin Exp Allergy; 2017 Apr; 47(4):551-564. PubMed ID: 27743410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-33 from Monocytes Recruited to the Lung Contributes to House Dust Mite-Induced Airway Inflammation in a Mouse Model.
    Tashiro H; Takahashi K; Hayashi S; Kato G; Kurata K; Kimura S; Sueoka-Aragane N
    PLoS One; 2016; 11(6):e0157571. PubMed ID: 27310495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. House Dust Mite-Specific Sublingual Immunotherapy Prevents the Development of Allergic Inflammation in a Mouse Model of Experimental Asthma.
    Hagner S; Rask C; Brimnes J; Andersen PS; Raifer H; Renz H; Garn H
    Int Arch Allergy Immunol; 2016; 170(1):22-34. PubMed ID: 27287860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP inhibition treatment in a nonconventional experimental mouse model of chronic asthma.
    Zaffini R; Di Paola R; Cuzzocrea S; Menegazzi M
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1301-1313. PubMed ID: 27604227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.